Cremecomtrsbi Dl 001 Stock EBITDA
| WY52 Stock | EUR 0.19 0.07 26.92% |
CREMECOMTRSBI DL 001 fundamentals help investors to digest information that contributes to CREMECOMTRSBI's financial success or failures. It also enables traders to predict the movement of CREMECOMTRSBI Stock. The fundamental analysis module provides a way to measure CREMECOMTRSBI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CREMECOMTRSBI stock.
CREMECOMTRSBI |
CREMECOMTRSBI DL 001 Company EBITDA Analysis
CREMECOMTRSBI's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current CREMECOMTRSBI EBITDA | 36.01 M |
Most of CREMECOMTRSBI's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CREMECOMTRSBI DL 001 is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
| Competition |
According to the company disclosure, CREMECOMTRSBI DL 001 reported earnings before interest,tax, depreciation and amortization of 36.01 M. This is 95.15% lower than that of the Real Estate sector and significantly higher than that of the REIT—Office industry. The ebitda for all Germany stocks is 99.08% higher than that of the company.
CREMECOMTRSBI EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CREMECOMTRSBI's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CREMECOMTRSBI could also be used in its relative valuation, which is a method of valuing CREMECOMTRSBI by comparing valuation metrics of similar companies.CREMECOMTRSBI is rated below average in ebitda category among its peers.
CREMECOMTRSBI Fundamentals
| Return On Equity | 0.014 | |||
| Return On Asset | 0.0151 | |||
| Profit Margin | 0.06 % | |||
| Operating Margin | 0.16 % | |||
| Shares Outstanding | 22.74 M | |||
| Shares Owned By Insiders | 13.49 % | |||
| Shares Owned By Institutions | 59.07 % | |||
| Price To Earning | 4.83 X | |||
| Revenue | 101.34 M | |||
| Gross Profit | 42.62 M | |||
| EBITDA | 36.01 M | |||
| Net Income | (30.95 M) | |||
| Cash And Equivalents | 59.73 M | |||
| Cash Per Share | 2.56 X | |||
| Total Debt | 260.72 M | |||
| Debt To Equity | 0.64 % | |||
| Current Ratio | 7.28 X | |||
| Book Value Per Share | 1.71 X | |||
| Cash Flow From Operations | 25.43 M | |||
| Earnings Per Share | (0.65) X | |||
| Target Price | 13.0 | |||
| Beta | 0.54 | |||
| Market Capitalization | 115.29 M | |||
| Annual Yield | 0.07 % | |||
| Five Year Return | 3.73 % | |||
| Last Dividend Paid | 0.33 |
About CREMECOMTRSBI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CREMECOMTRSBI DL 001's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CREMECOMTRSBI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CREMECOMTRSBI DL 001 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in CREMECOMTRSBI Stock
CREMECOMTRSBI financial ratios help investors to determine whether CREMECOMTRSBI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CREMECOMTRSBI with respect to the benefits of owning CREMECOMTRSBI security.